Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Brinker

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|February 2, 2002
Use of a spontaneous adverse drug events database for identification of unanticipated drug benefitsAllen Brinker, Julie Beitz
Archives of Dermatology|May 18, 2005
Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART programAllen Brinker, Cynthia Kornegay, Parivash Nourjah
Journal of the American Pharmacists Association : Japha|July 3, 2003
Changes in ciprofloxacin utilization as shown in a large pharmacy claims database: effects of proximity to criminal anthrax exposure in October 2001Allen Brinker, Carol Pamer, Julie Beitz
JAMA Dermatology|December 13, 2018
Association of Noninfectious Pneumonia With Ustekinumab UseAllen Brinker, Carmen Cheng, Vicky Chan
Journal of Interventional Cardiology|July 27, 2002
Ambulatory use of ticlopidine and clopidogrel in association with percutaneous coronary revascularization procedures in a national managed care organizationDeborah Shatin, Stephanie D Schech, Allen Brinker
The American Journal of Gastroenterology|May 16, 2006
Alosetron: ischemic colitis and serious complications of constipationHugo Gallo-Torres, Allen Brinker, Mark Avigan
Drugs & Aging|May 11, 2004
Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozinAllen Brinker, Lawrence Goldkind, Renan Bonnel, et al.
Drug Safety|July 3, 2007
An observational study of cholecystectomy in patients receiving tegaserodAllen Brinker, Stephanie D Schech, Margaret Burgess, et al.
American Journal of Hematology|June 24, 2006
New-onset and idiopathic thrombotic thrombocytopenic purpura: incidence, diagnostic validity, and potential risk factorsStephanie D Schech, Allen Brinker, Deborah Shatin, et al.
Annals of Internal Medicine|November 21, 2007
Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximabAngela Raval, Gita Akhavan-Toyserkani, Allen Brinker, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|February 2, 2002
Use of a spontaneous adverse drug events database for identification of unanticipated drug benefitsAllen Brinker, Julie Beitz
Archives of Dermatology|May 18, 2005
Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART programAllen Brinker, Cynthia Kornegay, Parivash Nourjah
Journal of the American Pharmacists Association : Japha|July 3, 2003
Changes in ciprofloxacin utilization as shown in a large pharmacy claims database: effects of proximity to criminal anthrax exposure in October 2001Allen Brinker, Carol Pamer, Julie Beitz
JAMA Dermatology|December 13, 2018
Association of Noninfectious Pneumonia With Ustekinumab UseAllen Brinker, Carmen Cheng, Vicky Chan
Journal of Interventional Cardiology|July 27, 2002
Ambulatory use of ticlopidine and clopidogrel in association with percutaneous coronary revascularization procedures in a national managed care organizationDeborah Shatin, Stephanie D Schech, Allen Brinker
The American Journal of Gastroenterology|May 16, 2006
Alosetron: ischemic colitis and serious complications of constipationHugo Gallo-Torres, Allen Brinker, Mark Avigan
Drugs & Aging|May 11, 2004
Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozinAllen Brinker, Lawrence Goldkind, Renan Bonnel, et al.
Drug Safety|July 3, 2007
An observational study of cholecystectomy in patients receiving tegaserodAllen Brinker, Stephanie D Schech, Margaret Burgess, et al.
American Journal of Hematology|June 24, 2006
New-onset and idiopathic thrombotic thrombocytopenic purpura: incidence, diagnostic validity, and potential risk factorsStephanie D Schech, Allen Brinker, Deborah Shatin, et al.
Annals of Internal Medicine|November 21, 2007
Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximabAngela Raval, Gita Akhavan-Toyserkani, Allen Brinker, et al.
Pageof 3